Page last updated: 2024-09-03

2'-cyano-2'-deoxyarabinofuranosylcytosine and isoflurophate

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with isoflurophate in 1 studies

Compound Research Comparison

Studies
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Trials
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Recent Studies (post-2010)
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Studies
(isoflurophate)
Trials
(isoflurophate)
Recent Studies (post-2010) (isoflurophate)
31063,3371123

Protein Interaction Comparison

ProteinTaxonomy2'-cyano-2'-deoxyarabinofuranosylcytosine (IC50)isoflurophate (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.48
Lysosomal protective proteinHomo sapiens (human)10
Fatty acid synthase Rattus norvegicus (Norway rat)0.05
AcetylcholinesteraseHomo sapiens (human)0.12
Liver carboxylesteraseSus scrofa (pig)0.05

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eshima, K; Fukushima, M; Iizuka, K; Jin, C; Zhang, C1

Other Studies

1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and isoflurophate

ArticleYear
Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.
    International journal of oncology, 2018, Volume: 52, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Deoxycytidine; DNA Breaks, Double-Stranded; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Infusions, Intravenous; Isoflurophate; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays

2018